| 구조 |
화학 이름 |
CAS |
MF |
 |
1,3-다이아미노프로판다이말리에이트 |
36703-88-5 |
C24H34N6O9 |
 |
이미퀴모드 |
99011-02-6 |
C14H16N4 |
 |
멜라토닌 |
73-31-4 |
C13H16N2O2 |
 |
Mizoribine |
50924-49-7 |
C9H13N3O6 |
 |
시롤리무스 |
53123-88-9 |
C51H79NO13 |
 |
에베로리무스 |
159351-69-6 |
C53H83NO14 |
 |
디아세레인 |
13739-02-1 |
C19H12O8 |
 |
탈마피모드 |
309913-83-5 |
C27H30ClFN4O3 |
 |
Enolicam |
73574-69-3 |
C17H13Cl3NNaO5S |
 |
FANETIZOLE MESYLATE |
79069-95-7 |
C18H20N2O3S2 |
 |
Immunoglobulin G1, anti-(human interferon g) (human-mouse monoclonal HuZAF g1-chain), disulfide with human-mouse monoclonal HuZAF light chain, dimer |
326859-36-3 |
|
|
|
5-73-Macrophageinflammatory protein 2a (human gene gro2) |
246861-96-1 |
C325H557N97O95S6 |
|
|
CNTO 148 |
476181-74-5 |
|
|
|
레너셉트 |
156679-34-4 |
|
 |
1-(5-히드록시헥실)-3,7-디메틸-퓨린-2,6-디온 |
100324-81-0 |
C13H20N4O3 |
 |
메리메포딕,VI-21497,VX-497 |
198821-22-6 |
C23H24N4O6 |
 |
Moxilubant maleate |
147398-01-4 |
C30H41N3O8 |
 |
2-morpholin-4-ylethyl (E)-6-(4-hydroxy-6-methoxy-7-methyl-3-oxo-1H-isobenzofuran-5-yl)-4-methyl-hex-4-enoate hydrochloride |
116680-01-4 |
C23H32ClNO7 |
![(3S,11S)-N-[(2R,3S)-2-ethoxy-5-oxo-oxolan-3-yl]-3-(isoquinoline-1-carbonylamino)-2,6-dioxo-1,7-diazabicyclo[5.4.0]undecane-11-carboxamide](/CAS/GIF/192755-52-5.gif) |
(3S,11S)-N-[(2R,3S)-2-ethoxy-5-oxo-oxolan-3-yl]-3-(isoquinoline-1-carbonylamino)-2,6-dioxo-1,7-diazabicyclo[5.4.0]undecane-11-carboxamide |
192755-52-5 |
C26H29N5O7 |
 |
Forigerimod acetate |
1160237-55-7 |
C119H185N34O34PS |
|
|
Sirukumab |
1194585-53-9 |
|
|
|
[4-methyl-5-[(2E,4E)-5-phenylpenta-2,4-dienoyl]-1,3-thiazol-2-yl]thiourea |
1236126-45-6 |
|
|
|
Rontalizumab |
948570-30-7 |
|
|
|
락시바쿠맙 |
565451-13-0 |
|
 |
우미롤리무스 |
851536-75-9 |
C55H87NO14 |
|
|
Pifonakin [inn] |
112721-39-8 |
|
 |
로퀴니멕스 |
84088-42-6 |
C18H16N2O3 |
|
|
Sifalimumab |
1006877-41-3 |
|
|
|
아캄2000 |
860435-78-5 |
|
|
|
오프레베킨 |
145941-26-0 |
|
|
|
h5G1.1-scFv |
219685-93-5 |
|
 |
Dirucotide acetate |
781666-30-6 |
C100H157N25O34 |
|
|
Briakinumab |
339308-60-0 |
|
 |
L-Tyrosine, polymer with L-alanine, L-lysine and L-phenylalanine |
507277-44-3 |
(C9H11NO3.C9H11NO2.C6H14N… |
|
|
페그나르토그라스티임 |
204565-76-4 |
|
|
|
Nerelimomab [usan:inn] |
162774-06-3 |
|
 |
Prinomide tromethamine |
109636-76-2 |
C15H13N3O2.C4H11NO3 |
|
|
sarilumab |
1189541-98-7 |
|
|
|
Mavrilimumab |
1085337-57-0 |
|
 |
Rapamycin, 27-deoxo- |
186752-78-3 |
C51H81NO12 |
 |
피라졸락 |
71002-09-0 |
C17H12ClFN2O2 |
 |
오르고테인 |
9016-01-7 |
Cu4Zn4+16 |
 |
피르티아놀 |
78092-66-7 |
C8H14NO5PS |
|
|
Immunoglobulin G1,anti-(human CD4 (antigen)) (human-mouse monoclonal cm-T412 g1-chain), disulfide withhuman-mouse monoclonal cm-T412 k-chain, dimer |
147191-91-1 |
|
 |
로마자리 |
109543-76-2 |
C15H16ClNO4 |
 |
Forigerimod |
497156-60-2 |
C117H181N34O32PS |
|
|
Pateclizumab |
1202526-59-7 |
|
|
|
아타시셉트 |
845264-92-8 |
|
 |
Unii-Q60au1llnu |
237068-57-4 |
C16H17N3Na2O5 |
 |
L-트레오닌,L-a-아스파르틸-L-a-글루타밀-L-아스파라기닐-L-프롤릴-L-발릴-L-발릴-L-히스티딜-L-페닐알라닐-L-페닐알라닐-L-리실-L-아스파라기닐-L-이소류실-L-발릴-L-트레오닐-L-프롤일-L-아르기니 |
152074-97-0 |
C92H141N25O26 |
|
|
Bezlotoxumab |
1246264-45-8 |
|
|
|
면역글로불린G2 |
1129435-60-4 |
|
 |
Oxamisole hydrochloride |
99258-55-6 |
C15H21ClN2O2 |
|
|
Siltuximab |
541502-14-1 |
|
 |
2-아세틸티오메틸-3-(4-메틸벤조일)프로피온산 |
101973-77-7 |
C14H16O4S |
|
|
6XJF4EZC5Z |
911338-45-9 |
|
|
|
Enoticumab |
1192578-27-0 |
|
|
|
Obexelimab |
1690307-05-1 |
|
|
|
Lanadelumab |
1426055-14-2 |
|
 |
아미셀리모드(MT-1303)염산염 |
942398-84-7 |
C19H31ClF3NO3 |
 |
Ruclosporin |
882569-97-3 |
C68H122N12O14 |
|
|
Peginterferon beta-1a |
1211327-92-2 |
|
 |
Adavivint |
1467093-03-3 |
C29H24FN7O |
|
|
Anifrolumab |
1326232-46-5 |
|
|
|
Birtamimab |
1608108-91-3 |
|
|
|
Narsoplimab |
2108782-45-0 |
|
 |
AMifaMpridine Phosphate |
446254-47-3 |
C5H10N3O4P |
|
|
Interleukin 2 (human),N-L-methionyl- |
136279-32-8 |
|
|
|
Spartalizumab |
1935694-88-4 |
|
|
|
Dostarlimab |
2022215-59-2 |
|
|
|
Cobolimab |
2022215-65-0 |
|
|
|
Lodapolimab |
2118349-31-6 |
|
![Benzeneacetic acid, α-methyl-4-(2-methylpropyl)-, mixt. with 3-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanimidamide](/CAS/20250703/GIF/1011231-26-7.gif) |
Benzeneacetic acid, α-methyl-4-(2-methylpropyl)-, mixt. with 3-[[[2-[(aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanimidamide |
1011231-26-7 |
C13H18O2.C8H15N7O2S3 |
 |
Avadomide hydrochloride |
1398053-45-6 |
C14H15ClN4O3 |
|
|
Relatlimab |
1673516-98-7 |
|
|
|
Pegcetacoplan |
2019171-69-6 |
|
|
|
Research Grade Valziflocept |
1804910-11-9 |
|
 |
PF-04171327 |
1044535-58-1 |
C29H30F3N2O5P |
 |
Petesicatib |
1252637-35-6 |
C25H23F6N5O4S |
|
|
Satralizumab |
1535963-91-7 |
|
|
|
Tibulizumab |
1849636-24-3 |
|
|
|
Cemiplimab |
1801342-60-8 |
|
 |
프레드니솔론파네실레이트 |
118244-44-3 |
C36H50O6 |
|
|
Iscalimab |
2031153-61-2 |
|
|
|
인터페론베타-1b |
145155-23-3 |
|
 |
Upadacitinib tartrate |
1607431-21-9 |
C21H25F3N6O7 |
 |
Veledimex |
1093130-72-3 |
C27H38N2O3 |
 |
Reltecimod sodium |
1943755-99-4 |
C46H73N10NaO15S |
|
|
Obiltoxaximab |
1351337-07-9 |
|
|
|
dinutuximab |
1363687-32-4 |
|
|
|
Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer |
1803171-55-2 |
|
|
|
Otilimab |
1638332-55-4 |
|
|
|
Bleselumab |
1453067-91-8 |
|
 |
구스페리무스3HCL |
85468-01-5 |
C17H37N7O3.3ClH |
 |
Reltecimod |
1447799-33-8 |
C46H72N10O15S |
|
|
Vobarilizumab |
1628814-88-9 |
|
 |
(4bS,7R,8aR)-4b-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-5,6,8,8a,9,10-hexahydrophenanthrene-2-carboxamide |
1044535-52-5 |
C29H29F3N2O2 |
 |
Leniolisib phosphate |
1354691-97-6 |
C21H28F3N6O6P |
|
|
Burosumab |
1610833-03-8 |
|
|
|
Etigilimab |
2044984-83-8 |
|